Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Intranasal Ketorolac Tromethamine Prescribed Postoperatively After Major Female Pelvic Reconstructive Surgery Reduce Consumption of Prescribed Narcotics?

NCT04444830 is registered in ClinicalTrials.gov with University of Louisville as lead sponsor.

NCT NCT04444830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04444830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Intranasal Ketorolac Tromethamine Prescribed Postoperatively After Major Female Pelvic Reconstructive Surgery Reduce Consumption of Prescribed Narcotics?
Lead sponsor
University of Louisville
Phase
Phase 4
Overall status
Withdrawn
Start date
January 31, 2021
Completion date
September 21, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

narcotic use, pelvic organ prolapse, post operative pain control, surgery, urinary incontinence , stress